BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

610 related articles for article (PubMed ID: 11531922)

  • 21. A mutation in the fibroblast growth factor receptor 1 gene causes fully penetrant normosmic isolated hypogonadotropic hypogonadism.
    Xu N; Qin Y; Reindollar RH; Tho SP; McDonough PG; Layman LC
    J Clin Endocrinol Metab; 2007 Mar; 92(3):1155-8. PubMed ID: 17200176
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Congenital idiopathic hypogonadotropic hypogonadism: evidence of defects in the hypothalamus, pituitary, and testes.
    Sykiotis GP; Hoang XH; Avbelj M; Hayes FJ; Thambundit A; Dwyer A; Au M; Plummer L; Crowley WF; Pitteloud N
    J Clin Endocrinol Metab; 2010 Jun; 95(6):3019-27. PubMed ID: 20382682
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutation analysis of the KAL gene in female patients with gonadotropin-releasing hormone deficiency.
    Lee SH; Han JH; Cho SW; Lee WH; Cha KY; Lee MH
    Yonsei Med J; 2004 Feb; 45(1):107-12. PubMed ID: 15004876
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutations in CHD7, encoding a chromatin-remodeling protein, cause idiopathic hypogonadotropic hypogonadism and Kallmann syndrome.
    Kim HG; Kurth I; Lan F; Meliciani I; Wenzel W; Eom SH; Kang GB; Rosenberger G; Tekin M; Ozata M; Bick DP; Sherins RJ; Walker SL; Shi Y; Gusella JF; Layman LC
    Am J Hum Genet; 2008 Oct; 83(4):511-9. PubMed ID: 18834967
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [From gene to disease; hypogonatrophic hypogonadism and anosmia: Kallmann's syndrome].
    Voorhoeve PG; Delemarre-van de Waal HA
    Ned Tijdschr Geneeskd; 2004 Jun; 148(23):1142-4. PubMed ID: 15211964
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel fibroblast growth factor receptor 1 mutations in patients with congenital hypogonadotropic hypogonadism with and without anosmia.
    Trarbach EB; Costa EM; Versiani B; de Castro M; Baptista MT; Garmes HM; de Mendonca BB; Latronico AC
    J Clin Endocrinol Metab; 2006 Oct; 91(10):4006-12. PubMed ID: 16882753
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The neuroradiology of Kallmann's syndrome: a genotypic and phenotypic analysis.
    Quinton R; Duke VM; de Zoysa PA; Platts AD; Valentine A; Kendall B; Pickman S; Kirk JM; Besser GM; Jacobs HS; Bouloux PM
    J Clin Endocrinol Metab; 1996 Aug; 81(8):3010-7. PubMed ID: 8768867
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phenotypic continuum between Waardenburg syndrome and idiopathic hypogonadotropic hypogonadism in humans with SOX10 variants.
    Rojas RA; Kutateladze AA; Plummer L; Stamou M; Keefe DL; Salnikov KB; Delaney A; Hall JE; Sadreyev R; Ji F; Fliers E; Gambosova K; Quinton R; Merino PM; Mericq V; Seminara SB; Crowley WF; Balasubramanian R
    Genet Med; 2021 Apr; 23(4):629-636. PubMed ID: 33442024
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CCDC141 Mutations in Idiopathic Hypogonadotropic Hypogonadism.
    Turan I; Hutchins BI; Hacihamdioglu B; Kotan LD; Gurbuz F; Ulubay A; Mengen E; Yuksel B; Wray S; Topaloglu AK
    J Clin Endocrinol Metab; 2017 Jun; 102(6):1816-1825. PubMed ID: 28324054
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical, hormonal, and genetic characteristics of 25 Chinese patients with idiopathic hypogonadotropic hypogonadism.
    Liu Q; Yin X; Li P
    BMC Endocr Disord; 2022 Jan; 22(1):30. PubMed ID: 35090434
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular analysis of KAL-1, GnRH-R, NELF and EBF2 genes in a series of Kallmann syndrome and normosmic hypogonadotropic hypogonadism patients.
    Trarbach EB; Baptista MT; Garmes HM; Hackel C
    J Endocrinol; 2005 Dec; 187(3):361-8. PubMed ID: 16423815
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical assessment and mutation analysis of Kallmann syndrome 1 (KAL1) and fibroblast growth factor receptor 1 (FGFR1, or KAL2) in five families and 18 sporadic patients.
    Sato N; Katsumata N; Kagami M; Hasegawa T; Hori N; Kawakita S; Minowada S; Shimotsuka A; Shishiba Y; Yokozawa M; Yasuda T; Nagasaki K; Hasegawa D; Hasegawa Y; Tachibana K; Naiki Y; Horikawa R; Tanaka T; Ogata T
    J Clin Endocrinol Metab; 2004 Mar; 89(3):1079-88. PubMed ID: 15001591
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A recurrent missense mutation in the KAL gene in patients with X-linked Kallmann's syndrome.
    Maya-Nuñez G; Zenteno JC; Ulloa-Aguirre A; Kofman-Alfaro S; Mendez JP
    J Clin Endocrinol Metab; 1998 May; 83(5):1650-3. PubMed ID: 9589672
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Loss-of-function mutation in the prokineticin 2 gene causes Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism.
    Pitteloud N; Zhang C; Pignatelli D; Li JD; Raivio T; Cole LW; Plummer L; Jacobson-Dickman EE; Mellon PL; Zhou QY; Crowley WF
    Proc Natl Acad Sci U S A; 2007 Oct; 104(44):17447-52. PubMed ID: 17959774
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel homozygous deletion of segmental KAL1 and entire STS cause Kallmann syndrome and X-linked ichthyosis in a Chinese family.
    Xu H; Li Z; Wang T; Wang S; Liu J; Wang DW
    Andrologia; 2015 Dec; 47(10):1160-5. PubMed ID: 25597551
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Congenital Hypogonadotropic Hypogonadism with Anosmia and Gorlin Features Caused by a PTCH1 Mutation Reveals a New Candidate Gene for Kallmann Syndrome.
    Barraud S; Delemer B; Poirsier-Violle C; Bouligand J; Mérol JC; Grange F; Higel-Chaufour B; Decoudier B; Zalzali M; Dwyer AA; Acierno JS; Pitteloud N; Millar RP; Young J
    Neuroendocrinology; 2021; 111(1-2):99-114. PubMed ID: 32074614
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of olfactory and other developmental anomalies in patients with central hypogonadotropic hypogonadism.
    Della Valle E; Vezzani S; Rochira V; Granata AR; Madeo B; Genovese E; Pignatti E; Marino M; Carani C; Simoni M
    Front Endocrinol (Lausanne); 2013; 4():70. PubMed ID: 23760293
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Advances in Genetic Diagnosis of Kallmann Syndrome and Genetic Interruption.
    Liu Y; Zhi X
    Reprod Sci; 2022 Jun; 29(6):1697-1709. PubMed ID: 34231173
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutations in prokineticin 2 and prokineticin receptor 2 genes in human gonadotrophin-releasing hormone deficiency: molecular genetics and clinical spectrum.
    Cole LW; Sidis Y; Zhang C; Quinton R; Plummer L; Pignatelli D; Hughes VA; Dwyer AA; Raivio T; Hayes FJ; Seminara SB; Huot C; Alos N; Speiser P; Takeshita A; Van Vliet G; Pearce S; Crowley WF; Zhou QY; Pitteloud N
    J Clin Endocrinol Metab; 2008 Sep; 93(9):3551-9. PubMed ID: 18559922
    [TBL] [Abstract][Full Text] [Related]  

  • 40. GnRH neuronal development: insights into hypogonadotrophic hypogonadism.
    MacColl G; Quinton R; Bouloux PM
    Trends Endocrinol Metab; 2002 Apr; 13(3):112-8. PubMed ID: 11893524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.